Ensysce Biosciences, Inc.: Ensysce Biosciences Announces Pos

Ensysce Biosciences, Inc.: Ensysce Biosciences Announces Positive Bioequivalence Study Data of Novel TAAP Opioid PF614 and Provides Timing of Corporate Update Call

Ensysce Biosciences, Inc.: Ensysce Biosciences Announces Positive Bioequivalence Study Data of Novel TAAP Opioid PF614 and Provides Timing of Corporate Update Call

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Salt Lake City , Utah , United States , Lynn Kirkpatrick , Ensysce Biosciences , Shannon Devine , Matthew Johnston , Ensysce Biosciences Inc , Center Study To Evaluate The Pharmacokinetics , Regulatory Path For Clinical Development , Mz Group North America , Health Sciences , Ensysce Biosciences Company Contact , Critical Progress Toward , Regulatory Path , Clinical Development , Trypsin Activated Abuse Protected , Nily Osman , Chief Medical Officer , New Drug Application , Part Single Center Study , Multiple Ascending Oral Doses , Food Effect , Single Oral Doses , Healthy Adult , Biosciences San Diego , Trypsin Activated Abuse Protection , Multi Pill Abuse Resistance , Private Securities Litigation Reform Act , Biosciences Investor Relations Contact ,